Maximize Your Gains with IVZ: AI Trading Bot Generates 9.58% Return
Invesco Ltd. (IVZ), a leading global investment management firm, experienced significant gains of 9.58% through the utilization of an AI trading bot. This impressive performance highlights the potential of artificial intelligence in enhancing trading strategies and generating profitable outcomes.
The recent surge in IVZ's stock price indicates a positive market sentiment, suggesting the possibility of a rebound above the lower band. Technical analysis suggests that the stock may move toward the middle band, further reinforcing the potential for upward momentum.
Given this upward trajectory, traders are advised to carefully consider their investment options. One potential strategy is to purchase IVZ stock, capitalizing on the optimistic outlook and potential for further price appreciation. However, it is crucial for traders to conduct thorough research and analysis before making any investment decisions.
Another alternative worth exploring is call options. Call options provide the right, but not the obligation, to buy the underlying stock at a specified price within a predetermined timeframe. By purchasing call options on IVZ, traders can potentially benefit from any further upside movement in the stock price while limiting their risk to the premium paid for the options.
IVZ's RSI Indicator is remaining in oversold zone for 1 day
It is expected that a price bounce should occur soon.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IVZ advanced for three days, in of 300 cases, the price rose further within the following month. The odds of a continued upward trend are .
IVZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 13, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on IVZ as a result. In of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for IVZ turned negative on September 20, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IVZ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for IVZ entered a downward trend on August 31, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.574) is normal, around the industry mean (3.494). P/E Ratio (10.352) is within average values for comparable stocks, (30.596). Projected Growth (PEG Ratio) (2.596) is also within normal values, averaging (4.613). Dividend Yield (0.054) settles around the average of (0.071) among similar stocks. P/S Ratio (1.154) is also within normal values, averaging (78.145).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. IVZ’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IVZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
General Information
a provider of investment management services
Industry InvestmentManagers
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| QUAL | 132.59 | 0.18 | +0.14% |
| iShares MSCI USA Quality Factor ETF | |||
| FBCG | 28.74 | 0.03 | +0.09% |
| Fidelity® Blue Chip Growth ETF | |||
| ILDR | 17.08 | N/A | +0.03% |
| First Trust Innovation Leaders ETF | |||
| EFAX | 36.02 | -0.01 | -0.02% |
| SPDR® MSCI EAFE Fssl Ful Free RsrvETF | |||
| EUDG | 29.04 | -0.11 | -0.38% |
| WisdomTree Europe Quality Div Gr ETF | |||
IVZ and
Correlation & Price change
A.I.dvisor indicates that over the last year, IVZ has been closely correlated with BEN. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if IVZ jumps, then BEN could also see price increases.
| Ticker / NAME | Correlation To IVZ | 1D Price Change % | ||
|---|---|---|---|---|
| IVZ | 100% | -0.96% | ||
| BEN - IVZ | 84% Closely correlated | -0.64% | ||
| BLK - IVZ | 83% Closely correlated | -1.31% | ||
| TROW - IVZ | 79% Closely correlated | -0.69% | ||
| JHG - IVZ | 78% Closely correlated | -0.67% | ||
| APAM - IVZ | 75% Closely correlated | +0.27% | ||
More | ||||